1,336 results match your criteria: "Centre Hospitalier Universitaire de Bordeaux .[Affiliation]"

Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort.

Rheumatology (Oxford)

November 2024

Department of Rheumatology and National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, Hôpital Bicêtre, Université Paris-Saclay, Le Kremlin Bicêtre, France.

Objectives: To evaluate the effectiveness of short message service (SMS) and/or email reminders in improving influenza vaccination coverage rates among rheumatoid arthritis (RA) patients treated with anti-TNF therapies, and to identify factors associated with vaccination.

Methods: A nested randomized controlled trial in the ART e-cohort, an ongoing French nationwide multicentre prospective cohort of RA patients treated with anti-TNF therapy. Patients were 1:1 randomized, with stratification on age.

View Article and Find Full Text PDF

Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.

N Engl J Med

November 2024

From the QEII Health Sciences Centre, Dalhousie University, Halifax, NS (J.L.S., R.P., A.A.), Western University, London, ON (A.S.L.T., L.J.G.), the Population Health Research Institute (J.S.H.) and Hamilton Health Sciences Centre (G.A.), Hamilton, ON, the University of Ottawa Heart Institute (G.M.N., P.B.N.), the McGill University Health Centre (V.E.), the Montreal Heart Institute (L.R., K.D.), and Centre Hospitalier de l'Universitaire de Montreal (J.-M.R.), Montreal, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC (J.-F.R.), Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec (J.-F.S., I.N.), the University of British Columbia, Vancouver (M.D.), Kelowna General Hospital, Kelowna, BC (C.L.), the University of Ottawa, Ottawa (G.A.W.), and the University of Calgary, Calgary, AB (V.K., S.W.) - all in Canada; Vanderbilt University Medical Center, Nashville (W.G.S., A.K.); Centre Hospitalier Universitaire de Bordeaux, L'institut des Maladies du Rythme Cardiaque, Bordeaux (F.S.), and Centre Hospitalier Universitaire de Nancy, Nancy (C.C.) - both in France; and St. Mary's General Hospital, Passaic, NJ (U.J.).

Background: Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tachycardia. Whether catheter ablation is more effective than antiarrhythmic drugs as a first-line therapy in patients with ventricular tachycardia is uncertain.

View Article and Find Full Text PDF

Purpose: MYRF-related cardiac-urogenital syndrome (MYRF-CUGS) is a rare condition associated with heterozygous MYRF variants. The description of MYRF-CUGS phenotype is mostly based on postnatal cases and 36 affected individuals have been published so far. We aim now to delineate the prenatal phenotype of MYRF-CUGS by reporting clinical data from fetuses and neonates with a pathogenic MYRF variant.

View Article and Find Full Text PDF

Introduction: In 2021, among French women who smoked when they knew they were pregnant, 59% still smoked at the end of pregnancy. Support for pregnant women to stop smoking must include a structured organisational perspective. The main objective of the study is to evaluate the effectiveness of the 5A-QUIT-N organisational intervention on smoking cessation at delivery among pregnant women who smoke during pregnancy.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the link between air pollution and cataract surgery incidence in older adults in Bordeaux, France.
  • Researchers followed 829 participants aged 65 and older from 1999-2017, monitoring their cataract surgeries and estimating their long-term air pollution exposure.
  • Results showed that long-term exposure to nitrogen dioxide (NO) at levels ≥40 μg/m was significantly associated with increased incidence of cataract surgery, suggesting that meeting air quality standards could benefit public health.
View Article and Find Full Text PDF

Monkeypox clade IIb in France in 2023-2024.

Lancet Reg Health Eur

December 2024

Assistance Publique - Hôpitaux de Paris, Nord. Hôpital Bichat-Claude Bernard, Service des Maladies Infectieuses et Tropicales, F75018, Paris, France.

View Article and Find Full Text PDF

Inputs of pharmacoepidemiology in addictovigilance: How do they fit together?

Therapie

October 2024

Inserm, Aix-Marseille université, U1106, 13005 Marseille, France; Service de pharmacologie clinique et pharmacosurveillance, unité de pharmacoépidémiologie, Assistance publique-Hôpitaux de Marseille, 13009 Marseille, France; Service de pharmacologie clinique et pharmacosurveillance, centre d'évaluation et d'information sur la pharmacodépendance - addictovigilance, Assistance publique-Hôpitaux de Marseille, 13009 Marseille France.

The French Addictovigilance Network has been using data from the French Heath insurance since the late 1990s to assess prescription drug abuse. In this narrative review, we illustrate the inputs of pharmacoepidemiology in addictovigilance based on the experience of the French Addictovigilance Network. The review focuses on pharmacoepidemiology using the French National Health Data System.

View Article and Find Full Text PDF

A 65 kilobase deletion of the upstream TYR gene region in a family with oculocutaneous albinism type 1.

Gene

January 2025

Laboratoire Maladies Rares, Génétique et Métabolisme, Bordeaux University INSERM U1211, Bordeaux, France; Service de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France. Electronic address:

Oculocutaneous albinism type 1 is caused by variants in the TYR (tyrosinase) gene. We describe a family with two affected sibs who inherited the pathogenic missense TYR variant c.1146C > A;p.

View Article and Find Full Text PDF

Postoperative lymphopaenia as a risk factor for postoperative infections in cancer surgery: A prospective multicentre cohort study (the EVALYMPH study).

Eur J Anaesthesiol

March 2025

From the Département d'Anesthésie-Réanimation, Université Jean Monnet Saint Etienne, CHU Saint Etienne, F-42023, Saint Etienne, France (LP, GD, LF SM), the Service d'Anesthésie et de Réanimation, Université d'Aix Marseille, Assistance Publique Hôpitaux de Marseille,, Hôpital Nord, Marseille, France (BP, JA, ML), the Département d'Anesthésie Réanimation, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France (BB, PI), the Service d'Anesthésie Réanimation & Médecine Péri-opératoire, Centre Hospitalier Universitaire de Poitiers, Poitiers, 86021, France; Inserm U1070, Université de Poitiers, Poitiers, France (PAG, MB), the Service d'Anesthésie et de Réanimation, Hôpital Universitaire Louis Pradel, Hospices Civils de Lyon, 69500, Lyon, France (JLF), the Département Anesthésie et Réanimation, Centre Hospitalier Universitaire Nîmes, Nîmes, France (YG), the Service d'Anesthésie, Centre hospitalier et universitaire de Lille, F-59037 Lille, France (GL), the Service Anesthésie et Réanimation, Centre Medico-chirurgical Magellan, Centre Hospitalier Universitaire de Bordeaux, Pessac, France (AO), the Département d'Anesthésie et de Réanimation, Centre Hospitalier Universitaire de Caen, Caen, France (MOF), Service d'Anesthésie-Réanimation Chirurgicale NHC - Hôpitaux Universitaires de Strasbourg, 67094 Strasbourg cedex, France (PMM), AP-HP, 26930, Groupe Hospitalier Universitaire APHP-Sorbonne Université, site Pitié-Salpêtrière, Département d'Anesthésie Réanimation, F-75013, Paris, Île-de-France, France (DE), the Département d'Anesthésie et de Réanimation, Centre Hospitalier Universitaire, Dijon, France (BB), the Département d'Anesthésie, Réanimation et Médecine Périopératoire, Groupe Hospitalier Universitaire Cochin, Paris, France (AG), AP-HP Nord, the Département d'Anesthésie Réanimation, CHU Bichat-Claude-Bernard, Paris, France. Université Paris-Cité, France (PM), the Laboratoire d'immunologie et EA7426, Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, Lyon, France (GM), the Département d'Anesthésie et de Réanimation, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France (ACL), Direction de la Recherche Clinique, Centre Hospitalier Universitaire de Clermont-Ferrand, Unité de Biostatistiques, Clermont-Ferrand, France (BP).

Background: Stress due to surgical trauma decreases postoperative lymphocyte counts (LCs), potentially favouring the occurrence of postoperative infections (PIs).

Objectives: We aimed to determine whether postoperative lymphopaenia following thoracic or gastrointestinal cancer surgery is an independent risk factor for PIs and to identify modifiable factors related to anaesthesia and surgical procedures that might affect its occurrence.

Study Design: The EVALYMPH study was a prospective, multicentre cohort study with a 30-day patient follow-up.

View Article and Find Full Text PDF

Background: While advances in endovascular thrombectomy (EVT) have led to high reperfusion rates, most patients treated with EVT do not avoid disability. Post-reperfusion hemorrhagic transformation (HT) is a potential target for improving outcomes. This study examined pretreatment blood-brain barrier (BBB) disruption in tissue that would subsequently become part of the final infarct to evaluate its role in post-EVT HT.

View Article and Find Full Text PDF

Introduction: HIV replication leads to a change in lymphocyte phenotypes that impairs immune protection against opportunistic infections. We examined current HIV replication as an independent risk factor for tuberculosis (TB).

Methods: We included people living with HIV from 25 European cohorts 1983-2015.

View Article and Find Full Text PDF

Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study).

Clin Res Hepatol Gastroenterol

December 2024

Service de Gastroentérologie, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, and INSERM U1111-CIRI, Lyon, France.

Background: ReFLECT was a French, prospective, multicenter, observational cohort study evaluating the effectiveness and safety of the infliximab (IFX) biosimilar CT-P13 in a real-world setting. Here, we describe the results for adults with inflammatory bowel disease (IBD).

Methods: Eligible patients with IBD were recruited and received intravenous CT-P13 induction and/or maintenance therapy; patients were either naive to IFX (IFX-naive) or previously treated with IFX originator or another IFX biosimilar (IFX-switched).

View Article and Find Full Text PDF

Observational studies suggest a reduction in fatal or severe COVID-19 disease with the use of ACE2 inhibitors and statins. We implemented a randomized controlled tree-arm open label trial evaluating the benefits of adding telmisartan (TLM) or atorvastatin (ATV) to lopinavir boosted ritonavir (LPVr) on the SARS-CoV-2 nasopharyngeal viral load in patients with mild / moderate COVID-19 infection in Côte d'Ivoire. RT-PCR positive COVID-19 patients ≥ 18 years, with general or respiratory symptoms for less than 7 days were randomized (1:1:1) to receive LPVr (400 mg/100 mg twice daily), LPVr + TLM (10 mg once daily) or LPVr + ATV (20 mg once daily) for 10 days.

View Article and Find Full Text PDF

Background: In kidney transplantation, molecular diagnostics may be a valuable approach to improve the precision of the diagnosis. Using next-generation sequencing (NGS), we aimed to identify clinically relevant archetypes.

Methods: We conducted an Illumina bulk RNA sequencing on 770 kidney biopsies (540 kidney recipients) collected between 2006 and 2021 from 11 European centers.

View Article and Find Full Text PDF

Pulsed Field Ablation for Refractory Ventricular Arrhythmias in Patients With Left Ventricular Assist Devices.

JACC Clin Electrophysiol

December 2024

Institut Hospitalo-Universitaire Institut des Maladies du Rythme Cardiaque, Electrophysiology and Heart Modeling Institute, Bordeaux, France; Haut-Lévêque University Hospital, Bordeaux, France.

View Article and Find Full Text PDF

Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients.

Circ Cardiovasc Interv

November 2024

Department of Interventional Cardiology and Cardiothoracic Surgery, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, TX (N.S.K., M.J.R.).

Article Synopsis
  • A study compared transcatheter aortic valve replacement (TAVR) with traditional surgery in low-risk patients under 75 years old with severe aortic stenosis to evaluate safety and effectiveness over three years.* -
  • Results showed that TAVR patients had similar overall mortality rates but significantly fewer disabling strokes (0.6%) compared to surgery patients (2.9%), while TAVR also resulted in better valve performance.* -
  • Both treatment options had comparable low rates of valve reinterventions, but TAVR patients experienced higher rates of pacemaker implantation (21.0% vs. 7.1%).*
View Article and Find Full Text PDF

Background: Patients with acute basilar artery occlusion (BAO) and low-to-moderate symptoms (National Institutes of Health Stroke Scale [NIHSS] < 10) are poorly represented in thrombectomy trials. Our objective is to compare thrombectomy and best medical management (BMT) in this population.

Methods: We compared data of all consecutive patients presenting with an initial NIHSS < 10 and acute symptomatic BAO included in two registries.

View Article and Find Full Text PDF

Low-dose methadone added to another opioid for cancer pain: a multicentre prospective study.

Support Care Cancer

October 2024

AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, Service Soins Palliatifs, Accompagnement Et Soins de Support, 47-83 Bd de L'Hôpital, 75013, Paris, France.

Article Synopsis
  • * Conducted at 19 pain and palliative care centers, the study found significant reductions in pain ratings from baseline to day 14, indicating that patients experienced relief.
  • * The results showed that half of the participants responded positively to the treatment, with no serious adverse effects reported, supporting the idea of using low-dose methadone as a helpful addition to pain management strategies for cancer patients.
View Article and Find Full Text PDF
Article Synopsis
  • The phase III KEYNOTE-913 study focused on assessing the effectiveness and safety of pembrolizumab as a first-line treatment for advanced Merkel cell carcinoma (MCC).
  • Results indicated a 49% objective response rate among the 55 patients treated, with a median duration of response of 39.8 months and median overall survival of 24.3 months.
  • The treatment showed manageable side effects, with 69% of patients experiencing any grade adverse events, but only 24% facing severe issues, highlighting pembrolizumab's potential in this patient group.
View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the average 3-day hospital stay after robotic-assisted partial nephrectomy (RAPN) and aimed to identify which patients could safely undergo the procedure on an outpatient basis without significant complications.
  • Researchers analyzed data from 3,342 patients who had RAPN between 2010 and 2021, finding that overall complications occurred in almost 15% of cases, with significant complications occurring in about 3.6%.
  • Key risk factors for early significant complications within 72 hours post-surgery included longer clamping times and higher ASA scores, leading to the conclusion that patients with ASA scores greater than 2 and a clamping time under 20 minutes could be good candidates for outpatient surgery.
View Article and Find Full Text PDF

[Events and errors in radiation oncology: Conciliating perspectives to support care].

Cancer Radiother

November 2024

UMR_S 938, service d'oncologie radiothérapie, hôpital Tenon, centre de recherche Saint-Antoine, institut universitaire de cancérologie, Sorbonne université, AP-HP, Paris, France.

The term "event" covers a wide range of concrete situations in radiation oncology, from particularly intense radiation-related side effects to the possibility of technical or human error. Although quality procedures are an integral part of radiotherapy oncology department operations ensuring the analysis and prevention of such events, their occurrence during radiation treatment still has a significant impact on patients and their experience of the treatment process, as well as on health professionals. These practical, emotional and symbolic impacts are all the greater when the event occurs in the aftermath of an error.

View Article and Find Full Text PDF
Article Synopsis
  • ARID1A and ARID1B duplications are linked to Coffin-Siris syndrome, but ARID1B duplications have not been previously associated with a specific clinical phenotype until now.
  • A study analyzed 16 cases of ARID1A and 13 cases of ARID1B duplications, revealing that ARID1A duplications resulted in more severe symptoms, including intellectual disabilities and growth delays, while both groups displayed similar features.
  • The research identified unique DNA methylation patterns in ARID1A duplication patients, which differ from those with loss-of-function variants, suggesting the presence of a distinct clinical phenotype for both ARID1A and ARID1B duplications, indicating a new type of
View Article and Find Full Text PDF